过敏诊断市场规模、份额和成长分析（按产品/服务、检测方法、过敏原、最终用户和地区划分）－2026-2033年产业预测

全球过敏诊断市场规模预计在 2024 年达到 48 亿美元，从 2025 年的 53.3 亿美元成长到 2033 年的 122.8 亿美元，在预测期（2026-2033 年）内复合年增长率为 11%。

全球过敏诊断市场正经历显着增长，这主要得益于过敏性疾病的增加、诊断技术的进步以及公众对过敏检测意识的提高。常见的过敏性疾病，例如花粉症、气喘和食物过敏，由于各种环境和生活方式因素的影响而日益增加。皮肤点刺试验、体外检测和分子诊断等创新技术正在提高该领域的准确性和效率。然而，监管壁垒、先进诊断方法的高成本以及缺乏标准化等挑战可能会阻碍市场扩张。儘管存在这些障碍，但新兴的创新诊断方法、机器学习和人工智慧的整合以及医疗基础设施投资的不断增加，为过敏诊断领域的未来成长提供了巨大的机会。

推动全球过敏诊断市场发展的因素

个人化医疗的兴起正对过敏诊断市场产生重大影响。人们对能够全面了解个别过敏原易感性的过敏检测的需求日益增长，从而能够制定更个人化的治疗方案。专注于识别与过敏相关的特定生物标记的研发进展，正在提升制定个人化治疗策略的能力，进一步推动过敏诊断领域的发展。随着医疗保健朝着更个人化的方向发展，过敏诊断和治疗的准确性变得愈发重要，这将最终塑造过敏诊断的未来格局。

全球过敏诊断市场面临的限制因素

全球过敏诊断市场的成长正受到家用检测套组和自我诊断方法日益普及的阻碍。虽然这些家用过敏检测方案为患者提供了便利，但与检查室诊断相比，其准确性往往不足。这种偏好的转变可能导致对专业检测服务的需求下降，最终影响市场扩张。此外，患者倾向于尝试DIY方法和家庭疗法，这进一步削弱了传统过敏诊断产业。因此，对低准确性家用检测方案的依赖对整体市场发展构成了显着挑战。

全球过敏诊断市场趋势

全球过敏诊断市场的一个显着趋势是分子诊断技术的日益普及，包括过敏原成分检测和次世代定序等先进技术。这些技术提高了分子层面过敏原检测的准确性，从而能够根据患者的个别敏感性制定高度个人化的治疗方案。随着医疗机构认识到精准诊断的价值，提供个人化治疗的能力有望显着改善患者的治疗效果。此外，ELISA、PCR 和 NHS 等调查方法的广泛应用也进一步推动了市场的发展，有助于实现更精细、更有效的过敏管理方法。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

全球过敏诊断市场规模（依产品/服务划分）及复合年增长率（2026-2033 年）

• 检测试剂盒
• 装置
• 服务
• 消耗品

全球过敏诊断市场规模（按检测类型和复合年增长率划分）（2026-2033 年）

• 体内试验
• 体外试验

全球过敏诊断市场规模（按过敏原和复合年增长率划分）（2026-2033 年）

• 吸入性过敏原
• 食物过敏原
• 药物过敏原
• 其他过敏原

全球过敏诊断市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 诊断检查室
• 医院检查室
• 学术研究机构
• 其他最终用户

全球过敏诊断市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Canon Inc.（Minaris Medical America, Inc.）（Japan/US）
• Eurofins Scientific（Luxembourg）
• EUROIMMUN Medizinische Labordiagnostika AG（Revvity Inc.）（Germany/US）
• bioMerieux SA（France）
• Stallergenes Greer Ltd.（UK）
• HollisterStier Allergy（US）
• Omega Diagnostics Group PLC（UK）
• R-Biopharm AG（Germany）
• HYCOR Biomedical（US）
• Lincoln Diagnostics, Inc.（US）
• HOB Biotech Group Corp., Ltd.（China）
• Romer Labs Division Holding GmbH（Austria）
• AESKU.GROUP GmbH（Germany）
• Neogen Corporation（US）
• ALK-Abello A/S（Denmark）
• Abbott Laboratories（US）
• Phadia（part of Thermo Fisher Scientific）（Sweden/US）

结论与建议

Global Allergy Diagnostics Market size was valued at USD 4.80 Billion in 2024 and is poised to grow from USD 5.33 Billion in 2025 to USD 12.28 Billion by 2033, growing at a CAGR of 11% during the forecast period (2026-2033).

The global allergy diagnostics market is experiencing significant growth driven by the increasing prevalence of allergic conditions, advancements in diagnostic technologies, and heightened public awareness surrounding allergy testing. Common allergic disorders, including hay fever, asthma, and food allergies, are on the rise, attributable to various environmental and lifestyle factors. Innovations such as skin prick tests, in vitro testing, and molecular diagnostics are enhancing accuracy and efficiency within the sector. However, challenges such as regulatory hurdles, high costs of advanced diagnostics, and a lack of standardization may hinder market expansion. Despite these obstacles, emerging innovative diagnostic methods, the integration of machine learning and artificial intelligence, along with increased investment in healthcare infrastructure, present considerable opportunities for future growth within the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Diagnostics Market

The growing trend towards personalized medicine is significantly influencing the allergy diagnostics market. There is a rising demand for allergy testing that provides comprehensive insights into individual sensitivities, facilitating more tailored treatment options. Advances in research focused on identifying specific biomarkers linked to allergies enhance the capacity to develop customized treatment strategies, further propelling the growth of the allergy diagnostics sector. As healthcare moves towards more individualized approaches, the emphasis on precision in diagnosing and treating allergies is becoming increasingly crucial, ultimately shaping the future landscape of allergy diagnostics.

Restraints in the Global Allergy Diagnostics Market

The growth of the global allergy diagnostics market is being hindered by the increasing popularity of home testing kits and do-it-yourself approaches. While these home-based allergy testing solutions provide greater convenience for patients, they often lack the accuracy of laboratory-based diagnostics. This shift in preference can lead to a decline in the demand for professional testing services, ultimately impacting market expansion. Additionally, the tendency for patients to explore DIY methods and home remedies further detracts from the traditional allergy diagnostics industry. Consequently, reliance on less precise home testing options poses a notable challenge to overall market development.

Market Trends of the Global Allergy Diagnostics Market

The Global Allergy Diagnostics market is witnessing a significant trend towards the increased adoption of molecular diagnostics, which includes advanced techniques such as allergen component testing and next-generation sequencing. These technologies enhance the accuracy of allergen detection at the molecular level, leading to highly personalized treatment plans based on individual patient sensitivities. As healthcare providers recognize the value of precision diagnostics, the ability to deliver tailored therapies is expected to improve patient outcomes considerably. Additionally, the prevalent use of methodologies like ELISA, PCR, and NHS further fuels the market's evolution, contributing to a more sophisticated and effective approach to allergy management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Assay Kits
• Instruments
• Services
• Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2026-2033)

• Market Overview
• In-vivo Tests
• In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2026-2033)

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Laboratories
• Hospital-Based Laboratories
• Academic Research Institutes
• Other End Users

Global Allergy Diagnostics Market Size & CAGR (2026-2033)

• North America (Product & Services, Tests, Allergen, End User)
  • US
  • Canada
• Europe (Product & Services, Tests, Allergen, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Tests, Allergen, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Tests, Allergen, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Tests, Allergen, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phadia (part of Thermo Fisher Scientific) (Sweden/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations